Invesco Dorsey Wright Healthcare Momentum ETF PTH
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Net expense ratio
- 0.60%
- Net assets
- $235.2M
- Holdings
- 57
- 12-month distribution yield
- 2.60%
- Asset class
- Equity
Invesco Dorsey Wright Healthcare Momentum ETF (PTH) is an exchange-traded fund listed on the Nasdaq in the United States, issued by Invesco. Its category is Equity · US (equity). Its last price was US$58.79 on 20 Oct 2026. Its net expense ratio is 0.6% a year, from its prospectus dated 28 Aug 2025. It reported net assets of US$235.21 million as of 31 Jul 2026. Its latest holdings report lists 57 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$1.53 a unit, a 12-month distribution yield of 2.60%.
Fees
- Total annual operating expenses (gross)
- 0.72%
- Net, after fee waivers or reimbursements
- 0.60%
- Management fee
- 0.50%
- Prospectus date
- 28 Aug 2025
- Filed with the SEC
- 27 Aug 2025
Size and reporting
- Net assets
- $235,211,770
- Total assets
- $300,473,998
- Holdings as of
- 31 Jul 2026
- Report made public
- 28 Sep 2026 (59 days after the month end)
Top holdings
Largest 25 of 57 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | No identifier reported | 20.79% | $48.9M | Short-term investment vehicles (cash funds) | United States | USD |
| 2 | Invesco Private Government Fund | No identifier reported | 6.83% | $16.1M | Short-term investment vehicles (cash funds) | United States | USD |
| 3 | Guardant Health, Inc. | US40131M1099 | 4.97% | $11.7M | Equity (common) | United States | USD |
| 4 | Roivant Sciences Ltd. | BMG762791017 | 4.95% | $11.6M | Equity (common) | Bermuda | USD |
| 5 | Revolution Medicines, Inc. | US76155X1000 | 4.94% | $11.6M | Equity (common) | United States | USD |
| 6 | Axsome Therapeutics, Inc. | US05464T1043 | 4.12% | $9.7M | Equity (common) | United States | USD |
| 7 | BrightSpring Health Services, Inc. | US10950A1060 | 4.03% | $9.5M | Equity (common) | United States | USD |
| 8 | Liquidia Corp. | US53635D2027 | 3.01% | $7.1M | Equity (common) | United States | USD |
| 9 | Erasca, Inc. | US29479A1088 | 2.94% | $6.9M | Equity (common) | United States | USD |
| 10 | Oruka Therapeutics, Inc. | US6876041087 | 2.74% | $6.4M | Equity (common) | United States | USD |
| 11 | 10x Genomics, Inc. 10x Genomics, Inc., Class A | US88025U1097 | 2.27% | $5.3M | Equity (common) | United States | USD |
| 12 | Relay Therapeutics, Inc. | US75943R1023 | 2.25% | $5.3M | Equity (common) | United States | USD |
| 13 | Tango Therapeutics Inc. | US87583X1090 | 2.16% | $5.1M | Equity (common) | United States | USD |
| 14 | Travere Therapeutics, Inc. | US89422G1076 | 2.16% | $5.1M | Equity (common) | United States | USD |
| 15 | Oscar Health, Inc. Oscar Health, Inc., Class A | US6877931096 | 2.10% | $4.9M | Equity (common) | United States | USD |
| 16 | Illumina, Inc. | US4523271090 | 2.08% | $4.9M | Equity (common) | United States | USD |
| 17 | agilon health, Inc. | US00857U2069 | 2.07% | $4.9M | Equity (common) | United States | USD |
| 18 | Axogen, Inc. | US05463X1063 | 2.06% | $4.8M | Equity (common) | United States | USD |
| 19 | Arrowhead Pharmaceuticals, Inc. | US04280A1007 | 2.01% | $4.7M | Equity (common) | United States | USD |
| 20 | Spyre Therapeutics, Inc. | US00773J2024 | 2.01% | $4.7M | Equity (common) | United States | USD |
| 21 | Replimune Group, Inc. | US76029N1063 | 1.93% | $4.5M | Equity (common) | United States | USD |
| 22 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | 1.93% | $4.5M | Equity (common) | Ireland | USD |
| 23 | Moderna, Inc. | US60770K1079 | 1.90% | $4.5M | Equity (common) | United States | USD |
| 24 | Cytokinetics, Inc. | US23282W6057 | 1.89% | $4.4M | Equity (common) | United States | USD |
| 25 | Viatris Inc. | US92556V1061 | 1.82% | $4.3M | Equity (common) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 100.04% | |
| Short-term investment vehicles (cash funds) | 27.70% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 116.14% | |
| Bermuda | 4.95% | |
| Ireland | 3.02% | |
| British Virgin Islands | 1.51% | |
| Netherlands | 1.50% | |
| Jersey | 0.62% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 127.74% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 52.04% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $1.5260
- 12-month yield
- 2.60%
- Frequency
- Irregular
- Latest ex-date
- 22 Dec 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ($1.5260) ÷ latest price ($58.79) × 100 = 2.60%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (2 payments)
| Ex-date | Amount per unit |
|---|---|
| 22 Dec 2025 | $1.5260 |
| 24 Jun 2024 | $0.0250 |
Filings and sources
- Form N-PORT report for July 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000013104) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- PTH and VTI Vanguard Morningstar Total Stock Market ETF
- PTH and VOO Vanguard S&P 500 ETF
- PTH and IVV iShares Core S&P 500 ETF
- PTH and QQQ Invesco QQQ Trust, Series 1